skip to main content
Home
About Us
Leadership & Advisors
Contact Us
Products
Transplant
VitaGraft Liver
VitaGraft Kidney
Oncology
DetermaIO
DetermaCNI
Publications
Biopharma Services
Investors
iMDx Company Profile
Stock Information
Events & Presentations
SEC Filings
Analyst Coverage
News Releases
Quarterly Documents
Corporate Governance
Information Request
Contact Us
Go to...
Home
About Us
Leadership & Advisors
Contact Us
Products
Transplant
VitaGraft Liver
VitaGraft Kidney
Oncology
DetermaIO
DetermaCNI
Publications
Biopharma Services
Investor
iMDx Company Profile
Stock Information
Events & Presentations
SEC Filings
Analyst Coverage
News Releases
Quarterly Documents
Corporate Governance
Management Team
Board of Directors
Committees
Governance Documents
Board Diversity Matrix
Information Request
Contact Us
Email Alerts
Contact Us
.
News
Releases
Home
>
Investors
>
News Releases
>
2018
iMDx Company Profile
Stock Information
Events & Presentations
SEC Filings
Analyst Coverage
News Releases
Quarterly Documents
Corporate Governance
Management Team
Board of Directors
Committees
Governance Documents
Board Diversity Matrix
Information Request
Contact Us
Email Alerts
Print
Share page
Email
Facebook
Twitter
News Releases
Register for email alerts
.
All Categories
All Categories
General
Earnings
Corporate News
Date Descending
Date Descending
Date Ascending
2018
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Date
Title
Document
Date
Mar 08, 2018
Title
OncoCyte Announces Initial Results of DetermaVu™ Feasibility on New Platforms; Enhancements May Increase Lung Cancer Diagnostic Test’s Clinical Performance
Document
PDF
<<
<
1
2
3
>
>>
